Clinical profile of ITP in Children: A single center study
DOI:
https://doi.org/10.54361/Keywords:
ITP in children, Splenectomy, Steroid, IVIG, Chronic ITPAbstract
BACKGROUND: Idiopathic thrombocytopenia (ITP) is the most common bleeding disorder in children, characterized by immune mediated platelets destruction. Objective: The aim is to determine the clinical features, treatment and outcomes of children with ITP. PATIENTS AND METHODS: The files of 165 pediatric patients diagnosed and treated between January 1997 and September 2005 were retrospectively reviewed; data abstracted including age, gender, presenting clinical features, laboratory findings and treatment outcome. RESULTS: They were 98 males and 67 females patients (M:F) (1.5:1).The median age was 4 years and 6 months with a range between 1.5months -15 years. The most common presenting features were purpura in 92.7%, epistaxis 37%, and gum bleeding 17.5%. One hundred fifteen (70%) of the patients had platelets count less than 20.000/µl. One hundred fifty one Patients (94%) were treated. Steroids was given to 123 Patients with 89% response rate (110 patients), 13 patients did not respond to steroid therapy. Out of the 110 patient responded to steroid only 74 patient thrombocytes count had sustained the response to steroids. IVIG was given to 61 Patients. Forty six patients (75%) had a good response to IVIG but only 21 patients had a sustained response. Combined treatment of steroid and IVIG was given to 57 Patients, only 25 patients (28%) had response and none of them had sustained response. The 57patients had combined therapy were; 29 had combined steroid and IVIG from the start, while the other 28 patients were 13 patients who had steroid and they did not respond, and the other 15 patients had IVIG only but did not showed response. Nine patients had Splenectomy, 7patients (77.8%) responded and only two patients did not show response. One hundred fifty one (94%) Patients recovered within 4-8 weeks, 43 (26%) developed chronic ITP (persistent more than 6 months), nine children underwent splenectomy and was curative in 7 patients. Nine Patients recovered spontaneously, 11 patients have persistent thrombocytopenia, and 13 patients were lost follow up. Overall, 140 patients (85%) of 165 children recovered completely. CONCLUSION: Acute and chronic ITP in children are generally benign condition. Treatment decisions should follow guide line based on the clinical picture and platelets count. Splenectomy should be considered in chronic ITP with significant bleeding and for patients did not respond to medical treatment.
Downloads
References
Nugent DJ.CHILDREN immune thrombocytopenic purpura. Blood Rev 2002; 16:27- 29.
Lilleyman JS. Management of childhood idiopathic thrombocytopenic purpura. Br J Haematol 1999; 105: 871-5.
Bolton-Maggs PH, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet 1997; 350:620-3.
Lilleyman JS. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Pediatric Haematology forum of the British Society for Haematology Arch Dis child 1994; 71:251-3.
Vesely S. Buchanan G. Cohen A, Raskob G, George J. self reported diagnostic and management strategies n childhood idiopathic thrombocytopenic purpura results of a survey of practicing pediatric haematology-oncology specialist. Pediatric Hematol oncol 2000; 22:55-61.
Eden OB Lilleyman JS. Guidelines for management of Idiopathic thrombocytopenic purpura. The British Paediatric Hematology Group.Arch Dis Child 1992; 67: 1056-8.
Tamary H. Kaplinsky c, Levy I. et al. Chronic childhood idiopathic thrombocytopenic purpura. Long term follow up. Acta Paediatric 1994; 83:931-4.
Chessells J. Chronic Idiopathic thrombocytopenic purpura : prim in non noceere Arch Dis Child 1989; 64:1326-8.
Taub JW, Warrier I, Holtkamp C. Beardsley DS, Lusher JM. Characterization of autoantibodies against the platelet glycoprotein antigens. Ib/IIIa in childhood idiopathic thrombocytopenic pupura. AM J Hematol 1995; 48:104-7.
Mc Verry BA Management of Idiopathic thrombocytopenic purpura Br. J Hematol 1985; 59:203-8.
Lowe EJ, Buchanan GR. Idiopathic thrombocytopenic purpura diagnosed during the second decade of life. J Pediatric 2002; 141:253-258.
El Alfy MS. Mkhtar GM, El-Laboudy MA, Khalifa AS. Acta Haematol. 2006; 115 (1-2): 46-52.
Watts RG Clin Pedia (Phila). 2004 Oct. 43 (8): 691-702.
George JN, Woolf SH, Raskob GE, et al: Idiopathic thrombocytopenic purpura: A practice guideline developed by eplicit methods for the American: society of Hematology, Blood 1996; 88:3.
Downloads
Published
Issue
Section
License
Copyright (c) 2017 Dr.Ramadan Allalous, Dr. Fathia Alriani, Dr. Amna Rayani (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access Policy
Libyan journal of medical Research (LJMR).is an open journal, therefore there are no fees required for downloading any publication from the journal website by authors, readers, and institution.
The journal applies the license of CC BY (a Creative Commons Attribution 4.0 International license). This license allows authors to keep ownership f the copyright of their papers. But this license permits any user to download , print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work.
The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
Editorial Policy
The publication of an article in a peer reviewed journal is an essential model for Libyan journal of medical Research (LJMR). It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editorial, the peer reviewer and the publisher.
Any manuscript or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party.
Authorship Policy
The manuscript authorship should be limited to those who have made a significant contribution and intellectual input to the research submitted to the journal, including design, performance, interpretation of the reported study, and writing the manuscript. All those who have made significant contributions should be listed as co-authors.
Others who have participated in certain substantive aspects of the manuscript but without intellectual input should only be recognized in the acknowledgements section of the manuscript. Also, one of the authors should be selected as the corresponding author to communicate with the journal and approve the final version of the manuscript for publication in the LJMR.
Peer-review Policy
- All the manuscripts submitted to LJMR will be subjected to the double-blinded peer-review process;
- The manuscript will be reviewed by two suitable experts in the respective subject area.
- Reports of all the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript.
- Editor-In-Chief will make the final decision, based on the reviewer’s comments.
- Editor-In-Chief can ask one or more advisory board members for their suggestions upon a manuscript, before making the final decision.
- Associate editor and review editors provide administrative support to maintain the integrity of the peer-review process.
- In case, authors challenge the editor’s negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.
